Washington DC Darvon Mass Drug Tort?
Posted on behalf of Goldberg Finnegan, LLC on Feb 04, 2009 in Drug Litigation
Medical advisers to the FDA have recommended the banning of Darvon, commonly known in its combination drug form, Darvocet (which also contains acetaminophen). Darvon has been in use for pain treatment for more than 50 years.
An advisory panel to the Food and Drug Administration recommended withdrawing Darvon from the market. Though not required to follow such recommendations, the FDA often does so.
Since its initial approval in 1957, Darvon, in its main incarnation as Darvocet, has become one of the top 25 most commonly prescribed medications, with over 20 million prescriptions written in 2007.
The review of Darvon was initiated by petition by a concerned citizen group, which has been calling for review of the drug since the 1970's. Drug manufacturers maintain that Darvon and Darvocet are safe and effective when used correctly.
Darvon was banned in the UK in 2005. The FDA may decide to do the same, or to enact stiffer warnings, additional safety studies, or other measures. In a review preceding this one, the FDS's internal safety office found more than 3,000 reports of serious problems related to Darvon, including suicide, drug dependence and overdoses.
It is possible that this news will lead to dangerous drug class action litigation, or individual drug torts. All those who have been negatively affected by Darvon or Darvocet and wish to explore legal action should contact a Washington DC drug litigation attorney immediately to assess the prospects of his or her case. This is perhaps the most important step in winning what you deserve through your case.